nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP2C9—brain cancer	0.475	1	CbGaD
Ticlopidine—MPO—Carboplatin—brain cancer	0.13	0.329	CbGbCtD
Ticlopidine—CYP2D6—Lomustine—brain cancer	0.0484	0.123	CbGbCtD
Ticlopidine—CYP1A2—Carmustine—brain cancer	0.0479	0.121	CbGbCtD
Ticlopidine—CYP2D6—Hydroxyurea—brain cancer	0.0367	0.093	CbGbCtD
Ticlopidine—CYP3A4—Temozolomide—brain cancer	0.0362	0.0918	CbGbCtD
Ticlopidine—CYP3A4—Lomustine—brain cancer	0.0308	0.0781	CbGbCtD
Ticlopidine—CYP2E1—Etoposide—brain cancer	0.0245	0.0623	CbGbCtD
Ticlopidine—CYP2C8—Etoposide—brain cancer	0.0183	0.0465	CbGbCtD
Ticlopidine—CYP1A2—Etoposide—brain cancer	0.0142	0.036	CbGbCtD
Ticlopidine—CYP3A4—Etoposide—brain cancer	0.00744	0.0189	CbGbCtD
Ticlopidine—Leukaemia—Hydroxyurea—brain cancer	0.00358	0.0503	CcSEcCtD
Ticlopidine—Clopidogrel—CYP2C9—brain cancer	0.00349	1	CrCbGaD
Ticlopidine—Lupus erythematosus—Hydroxyurea—brain cancer	0.00258	0.0364	CcSEcCtD
Ticlopidine—Contusion—Lomustine—brain cancer	0.00225	0.0316	CcSEcCtD
Ticlopidine—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.00174	0.0245	CcSEcCtD
Ticlopidine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00166	0.0314	CbGpPWpGaD
Ticlopidine—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00163	0.0307	CbGpPWpGaD
Ticlopidine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00149	0.0282	CbGpPWpGaD
Ticlopidine—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00148	0.028	CbGpPWpGaD
Ticlopidine—Bone marrow depression—Hydroxyurea—brain cancer	0.00143	0.0201	CcSEcCtD
Ticlopidine—Osteoarthritis—Lomustine—brain cancer	0.00142	0.02	CcSEcCtD
Ticlopidine—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00136	0.0258	CbGpPWpGaD
Ticlopidine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00136	0.0256	CbGpPWpGaD
Ticlopidine—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00134	0.0253	CbGpPWpGaD
Ticlopidine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00133	0.0252	CbGpPWpGaD
Ticlopidine—Nephropathy—Etoposide—brain cancer	0.00126	0.0178	CcSEcCtD
Ticlopidine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00121	0.0229	CbGpPWpGaD
Ticlopidine—Pancytopenia—Lomustine—brain cancer	0.00117	0.0164	CcSEcCtD
Ticlopidine—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00115	0.0218	CbGpPWpGaD
Ticlopidine—Renal failure—Lomustine—brain cancer	0.00108	0.0152	CcSEcCtD
Ticlopidine—Lung disorder—Temozolomide—brain cancer	0.00106	0.015	CcSEcCtD
Ticlopidine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00104	0.0196	CbGpPWpGaD
Ticlopidine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00103	0.0195	CbGpPWpGaD
Ticlopidine—Vascular purpura—Procarbazine—brain cancer	0.00101	0.0142	CcSEcCtD
Ticlopidine—Haemolytic anaemia—Procarbazine—brain cancer	0.001	0.0141	CcSEcCtD
Ticlopidine—Haemoglobin—Lomustine—brain cancer	0.000989	0.0139	CcSEcCtD
Ticlopidine—Haemorrhage—Lomustine—brain cancer	0.000984	0.0138	CcSEcCtD
Ticlopidine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000948	0.0179	CbGpPWpGaD
Ticlopidine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000943	0.0178	CbGpPWpGaD
Ticlopidine—Purpura—Procarbazine—brain cancer	0.000937	0.0132	CcSEcCtD
Ticlopidine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000846	0.016	CbGpPWpGaD
Ticlopidine—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000828	0.0157	CbGpPWpGaD
Ticlopidine—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000797	0.0151	CbGpPWpGaD
Ticlopidine—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.000781	0.0148	CbGpPWpGaD
Ticlopidine—Hepatic failure—Hydroxyurea—brain cancer	0.000778	0.0109	CcSEcCtD
Ticlopidine—Eosinophilia—Procarbazine—brain cancer	0.000773	0.0109	CcSEcCtD
Ticlopidine—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000751	0.0142	CbGpPWpGaD
Ticlopidine—Pancytopenia—Procarbazine—brain cancer	0.000741	0.0104	CcSEcCtD
Ticlopidine—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000716	0.0135	CbGpPWpGaD
Ticlopidine—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000689	0.013	CbGpPWpGaD
Ticlopidine—Thrombocytopenia—Lomustine—brain cancer	0.000685	0.00963	CcSEcCtD
Ticlopidine—Pain—Carboplatin—brain cancer	0.000683	0.00962	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Procarbazine—brain cancer	0.000682	0.0096	CcSEcCtD
Ticlopidine—Sepsis—Carmustine—brain cancer	0.000676	0.00951	CcSEcCtD
Ticlopidine—Anorexia—Lomustine—brain cancer	0.000666	0.00938	CcSEcCtD
Ticlopidine—Haematuria—Procarbazine—brain cancer	0.000664	0.00934	CcSEcCtD
Ticlopidine—Epistaxis—Procarbazine—brain cancer	0.000656	0.00924	CcSEcCtD
Ticlopidine—Diabetes mellitus—Carmustine—brain cancer	0.00065	0.00914	CcSEcCtD
Ticlopidine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000639	0.0121	CbGpPWpGaD
Ticlopidine—Body temperature increased—Carboplatin—brain cancer	0.000632	0.00889	CcSEcCtD
Ticlopidine—Haemoglobin—Procarbazine—brain cancer	0.000628	0.00884	CcSEcCtD
Ticlopidine—Haemorrhage—Procarbazine—brain cancer	0.000625	0.00879	CcSEcCtD
Ticlopidine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000615	0.0116	CbGpPWpGaD
Ticlopidine—Vascular purpura—Temozolomide—brain cancer	0.00061	0.00859	CcSEcCtD
Ticlopidine—Decreased appetite—Lomustine—brain cancer	0.000608	0.00855	CcSEcCtD
Ticlopidine—Hepatic failure—Temozolomide—brain cancer	0.000608	0.00855	CcSEcCtD
Ticlopidine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000588	0.0111	CbGpPWpGaD
Ticlopidine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000581	0.011	CbGpPWpGaD
Ticlopidine—Dermatitis exfoliative—Temozolomide—brain cancer	0.000579	0.00814	CcSEcCtD
Ticlopidine—Pancytopenia—Hydroxyurea—brain cancer	0.000574	0.00807	CcSEcCtD
Ticlopidine—Hyponatraemia—Carmustine—brain cancer	0.000567	0.00798	CcSEcCtD
Ticlopidine—Purpura—Temozolomide—brain cancer	0.000567	0.00797	CcSEcCtD
Ticlopidine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000565	0.0107	CbGpPWpGaD
Ticlopidine—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000565	0.00795	CcSEcCtD
Ticlopidine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000553	0.0105	CbGpPWpGaD
Ticlopidine—Body temperature increased—Lomustine—brain cancer	0.000553	0.00778	CcSEcCtD
Ticlopidine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000542	0.0102	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000528	0.00999	CbGpPWpGaD
Ticlopidine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000528	0.00743	CcSEcCtD
Ticlopidine—Sepsis—Etoposide—brain cancer	0.000522	0.00735	CcSEcCtD
Ticlopidine—Liver function test abnormal—Carmustine—brain cancer	0.000522	0.00734	CcSEcCtD
Ticlopidine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000498	0.00942	CbGpPWpGaD
Ticlopidine—Haemoglobin—Hydroxyurea—brain cancer	0.000486	0.00684	CcSEcCtD
Ticlopidine—Haemorrhage—Hydroxyurea—brain cancer	0.000484	0.0068	CcSEcCtD
Ticlopidine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000479	0.00906	CbGpPWpGaD
Ticlopidine—Abdominal distension—Temozolomide—brain cancer	0.000475	0.00669	CcSEcCtD
Ticlopidine—Pancytopenia—Carmustine—brain cancer	0.000464	0.00653	CcSEcCtD
Ticlopidine—Myalgia—Procarbazine—brain cancer	0.000463	0.00652	CcSEcCtD
Ticlopidine—Arthralgia—Procarbazine—brain cancer	0.000463	0.00652	CcSEcCtD
Ticlopidine—MPO—Vitamin B12 Metabolism—SOD2—brain cancer	0.000459	0.00868	CbGpPWpGaD
Ticlopidine—Pancytopenia—Temozolomide—brain cancer	0.000448	0.00631	CcSEcCtD
Ticlopidine—Vomiting—Lomustine—brain cancer	0.000445	0.00626	CcSEcCtD
Ticlopidine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000439	0.0083	CbGpPWpGaD
Ticlopidine—Thrombocytopenia—Procarbazine—brain cancer	0.000435	0.00612	CcSEcCtD
Ticlopidine—Renal failure—Carmustine—brain cancer	0.000428	0.00602	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Carmustine—brain cancer	0.000427	0.00601	CcSEcCtD
Ticlopidine—Anorexia—Procarbazine—brain cancer	0.000423	0.00595	CcSEcCtD
Ticlopidine—MPO—C-MYB transcription factor network—CDK6—brain cancer	0.00042	0.00793	CbGpPWpGaD
Ticlopidine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000417	0.00587	CcSEcCtD
Ticlopidine—Nausea—Lomustine—brain cancer	0.000415	0.00584	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Temozolomide—brain cancer	0.000412	0.0058	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000404	0.00569	CcSEcCtD
Ticlopidine—Cramp muscle—Etoposide—brain cancer	0.000393	0.00554	CcSEcCtD
Ticlopidine—Haemoglobin—Carmustine—brain cancer	0.000393	0.00553	CcSEcCtD
Ticlopidine—Haemorrhage—Carmustine—brain cancer	0.000391	0.0055	CcSEcCtD
Ticlopidine—Decreased appetite—Procarbazine—brain cancer	0.000386	0.00543	CcSEcCtD
Ticlopidine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000384	0.00727	CbGpPWpGaD
Ticlopidine—Haemoglobin—Temozolomide—brain cancer	0.00038	0.00534	CcSEcCtD
Ticlopidine—Pain—Procarbazine—brain cancer	0.00038	0.00534	CcSEcCtD
Ticlopidine—Haemorrhage—Temozolomide—brain cancer	0.000378	0.00532	CcSEcCtD
Ticlopidine—Hepatitis—Temozolomide—brain cancer	0.000378	0.00532	CcSEcCtD
Ticlopidine—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000375	0.0071	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—SOD2—brain cancer	0.000374	0.00706	CbGpPWpGaD
Ticlopidine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00037	0.00699	CbGpPWpGaD
Ticlopidine—Gastrointestinal pain—Procarbazine—brain cancer	0.000363	0.00511	CcSEcCtD
Ticlopidine—Pancytopenia—Etoposide—brain cancer	0.000359	0.00505	CcSEcCtD
Ticlopidine—Erythema multiforme—Temozolomide—brain cancer	0.000357	0.00503	CcSEcCtD
Ticlopidine—MPO—endothelium—brain cancer	0.000353	0.0927	CbGeAlD
Ticlopidine—Urticaria—Procarbazine—brain cancer	0.000353	0.00496	CcSEcCtD
Ticlopidine—Tinnitus—Temozolomide—brain cancer	0.000352	0.00496	CcSEcCtD
Ticlopidine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000351	0.00664	CbGpPWpGaD
Ticlopidine—Body temperature increased—Procarbazine—brain cancer	0.000351	0.00494	CcSEcCtD
Ticlopidine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000347	0.00655	CbGpPWpGaD
Ticlopidine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000344	0.0065	CbGpPWpGaD
Ticlopidine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000344	0.0065	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—RELA—brain cancer	0.000343	0.00649	CbGpPWpGaD
Ticlopidine—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000339	0.00642	CbGpPWpGaD
Ticlopidine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000336	0.00473	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000334	0.0047	CcSEcCtD
Ticlopidine—Renal failure—Etoposide—brain cancer	0.000331	0.00466	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Etoposide—brain cancer	0.00033	0.00464	CcSEcCtD
Ticlopidine—Anorexia—Hydroxyurea—brain cancer	0.000327	0.00461	CcSEcCtD
Ticlopidine—Hypersensitivity—Procarbazine—brain cancer	0.000327	0.0046	CcSEcCtD
Ticlopidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000326	0.00616	CbGpPWpGaD
Ticlopidine—MPO—blood vessel—brain cancer	0.000325	0.0855	CbGeAlD
Ticlopidine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000324	0.00613	CbGpPWpGaD
Ticlopidine—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00032	0.00605	CbGpPWpGaD
Ticlopidine—Asthenia—Procarbazine—brain cancer	0.000318	0.00448	CcSEcCtD
Ticlopidine—Pruritus—Procarbazine—brain cancer	0.000314	0.00442	CcSEcCtD
Ticlopidine—MPO—IL23-mediated signaling events—IL2—brain cancer	0.000309	0.00584	CbGpPWpGaD
Ticlopidine—MPO—C-MYB transcription factor network—HES1—brain cancer	0.000309	0.00584	CbGpPWpGaD
Ticlopidine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000307	0.00581	CbGpPWpGaD
Ticlopidine—Diarrhoea—Procarbazine—brain cancer	0.000304	0.00427	CcSEcCtD
Ticlopidine—Dyspepsia—Hydroxyurea—brain cancer	0.000302	0.00426	CcSEcCtD
Ticlopidine—Angioedema—Temozolomide—brain cancer	0.0003	0.00423	CcSEcCtD
Ticlopidine—Decreased appetite—Hydroxyurea—brain cancer	0.000299	0.0042	CcSEcCtD
Ticlopidine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000297	0.00562	CbGpPWpGaD
Ticlopidine—MPO—Selenium Micronutrient Network—SOD2—brain cancer	0.000297	0.00561	CbGpPWpGaD
Ticlopidine—Pain—Hydroxyurea—brain cancer	0.000294	0.00413	CcSEcCtD
Ticlopidine—Dizziness—Procarbazine—brain cancer	0.000294	0.00413	CcSEcCtD
Ticlopidine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000293	0.00555	CbGpPWpGaD
Ticlopidine—Myalgia—Carmustine—brain cancer	0.00029	0.00408	CcSEcCtD
Ticlopidine—Erythema multiforme—Etoposide—brain cancer	0.000286	0.00402	CcSEcCtD
Ticlopidine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000285	0.00538	CbGpPWpGaD
Ticlopidine—Vomiting—Procarbazine—brain cancer	0.000282	0.00397	CcSEcCtD
Ticlopidine—Arthralgia—Temozolomide—brain cancer	0.00028	0.00394	CcSEcCtD
Ticlopidine—Myalgia—Temozolomide—brain cancer	0.00028	0.00394	CcSEcCtD
Ticlopidine—Rash—Procarbazine—brain cancer	0.00028	0.00394	CcSEcCtD
Ticlopidine—Dermatitis—Procarbazine—brain cancer	0.00028	0.00393	CcSEcCtD
Ticlopidine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000279	0.00527	CbGpPWpGaD
Ticlopidine—Headache—Procarbazine—brain cancer	0.000278	0.00391	CcSEcCtD
Ticlopidine—P2RY12—Hemostasis—MPL—brain cancer	0.000272	0.00515	CbGpPWpGaD
Ticlopidine—Thrombocytopenia—Carmustine—brain cancer	0.000272	0.00383	CcSEcCtD
Ticlopidine—Body temperature increased—Hydroxyurea—brain cancer	0.000272	0.00382	CcSEcCtD
Ticlopidine—P2RY12—GPCR ligand binding—PTCH2—brain cancer	0.000271	0.00513	CbGpPWpGaD
Ticlopidine—Anaphylactic shock—Temozolomide—brain cancer	0.000268	0.00378	CcSEcCtD
Ticlopidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000265	0.00502	CbGpPWpGaD
Ticlopidine—MPO—Vitamin B12 Metabolism—RELA—brain cancer	0.000265	0.00502	CbGpPWpGaD
Ticlopidine—Anorexia—Carmustine—brain cancer	0.000265	0.00373	CcSEcCtD
Ticlopidine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000264	0.00499	CbGpPWpGaD
Ticlopidine—Nausea—Procarbazine—brain cancer	0.000264	0.00371	CcSEcCtD
Ticlopidine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000263	0.00497	CbGpPWpGaD
Ticlopidine—Thrombocytopenia—Temozolomide—brain cancer	0.000263	0.0037	CcSEcCtD
Ticlopidine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000262	0.00495	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—S100A10—brain cancer	0.000261	0.00494	CbGpPWpGaD
Ticlopidine—MPO—IL23-mediated signaling events—STAT3—brain cancer	0.00026	0.00492	CbGpPWpGaD
Ticlopidine—Anorexia—Temozolomide—brain cancer	0.000256	0.0036	CcSEcCtD
Ticlopidine—Hypersensitivity—Hydroxyurea—brain cancer	0.000253	0.00356	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000253	0.00356	CcSEcCtD
Ticlopidine—Muscle spasms—Etoposide—brain cancer	0.000253	0.00356	CcSEcCtD
Ticlopidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000251	0.00475	CbGpPWpGaD
Ticlopidine—Asthenia—Hydroxyurea—brain cancer	0.000246	0.00347	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000245	0.00344	CcSEcCtD
Ticlopidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000244	0.00462	CbGpPWpGaD
Ticlopidine—Decreased appetite—Carmustine—brain cancer	0.000241	0.0034	CcSEcCtD
Ticlopidine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000241	0.00456	CbGpPWpGaD
Ticlopidine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000241	0.00455	CbGpPWpGaD
Ticlopidine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000239	0.00452	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—OR14C36—brain cancer	0.000238	0.0045	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—OR4C12—brain cancer	0.000238	0.0045	CbGpPWpGaD
Ticlopidine—Pain—Carmustine—brain cancer	0.000237	0.00334	CcSEcCtD
Ticlopidine—Dyspepsia—Temozolomide—brain cancer	0.000236	0.00332	CcSEcCtD
Ticlopidine—Diarrhoea—Hydroxyurea—brain cancer	0.000235	0.00331	CcSEcCtD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000234	0.00442	CbGpPWpGaD
Ticlopidine—Decreased appetite—Temozolomide—brain cancer	0.000233	0.00328	CcSEcCtD
Ticlopidine—Pain—Temozolomide—brain cancer	0.00023	0.00323	CcSEcCtD
Ticlopidine—Dizziness—Hydroxyurea—brain cancer	0.000227	0.0032	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Carmustine—brain cancer	0.000227	0.0032	CcSEcCtD
Ticlopidine—P2RY12—endocrine gland—brain cancer	0.000227	0.0596	CbGeAlD
Ticlopidine—P2RY12—head—brain cancer	0.000224	0.0588	CbGeAlD
Ticlopidine—Body temperature increased—Carmustine—brain cancer	0.00022	0.00309	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Temozolomide—brain cancer	0.000219	0.00309	CcSEcCtD
Ticlopidine—Vomiting—Hydroxyurea—brain cancer	0.000218	0.00307	CcSEcCtD
Ticlopidine—Rash—Hydroxyurea—brain cancer	0.000217	0.00305	CcSEcCtD
Ticlopidine—Dermatitis—Hydroxyurea—brain cancer	0.000216	0.00305	CcSEcCtD
Ticlopidine—P2RY12—Signaling by GPCR—OR4C12—brain cancer	0.000216	0.00409	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—OR14C36—brain cancer	0.000216	0.00409	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—RELA—brain cancer	0.000216	0.00408	CbGpPWpGaD
Ticlopidine—Headache—Hydroxyurea—brain cancer	0.000215	0.00303	CcSEcCtD
Ticlopidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000215	0.00407	CbGpPWpGaD
Ticlopidine—Anaphylactic shock—Etoposide—brain cancer	0.000215	0.00302	CcSEcCtD
Ticlopidine—Urticaria—Temozolomide—brain cancer	0.000213	0.003	CcSEcCtD
Ticlopidine—Body temperature increased—Temozolomide—brain cancer	0.000212	0.00299	CcSEcCtD
Ticlopidine—Thrombocytopenia—Etoposide—brain cancer	0.00021	0.00296	CcSEcCtD
Ticlopidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000207	0.00391	CbGpPWpGaD
Ticlopidine—Anorexia—Etoposide—brain cancer	0.000205	0.00288	CcSEcCtD
Ticlopidine—Hypersensitivity—Carmustine—brain cancer	0.000205	0.00288	CcSEcCtD
Ticlopidine—P2RY12—central nervous system—brain cancer	0.000205	0.0537	CbGeAlD
Ticlopidine—Nausea—Hydroxyurea—brain cancer	0.000204	0.00287	CcSEcCtD
Ticlopidine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000204	0.00386	CbGpPWpGaD
Ticlopidine—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000202	0.00383	CbGpPWpGaD
Ticlopidine—Asthenia—Carmustine—brain cancer	0.000199	0.0028	CcSEcCtD
Ticlopidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000198	0.00374	CbGpPWpGaD
Ticlopidine—Hypersensitivity—Temozolomide—brain cancer	0.000198	0.00278	CcSEcCtD
Ticlopidine—MPO—Folate Metabolism—IL2—brain cancer	0.000194	0.00368	CbGpPWpGaD
Ticlopidine—Asthenia—Temozolomide—brain cancer	0.000193	0.00271	CcSEcCtD
Ticlopidine—Diarrhoea—Carmustine—brain cancer	0.00019	0.00267	CcSEcCtD
Ticlopidine—Pruritus—Temozolomide—brain cancer	0.00019	0.00267	CcSEcCtD
Ticlopidine—Decreased appetite—Etoposide—brain cancer	0.000187	0.00263	CcSEcCtD
Ticlopidine—MPO—C-MYB transcription factor network—CDKN2A—brain cancer	0.000185	0.0035	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—BSG—brain cancer	0.000184	0.00348	CbGpPWpGaD
Ticlopidine—Dizziness—Carmustine—brain cancer	0.000184	0.00258	CcSEcCtD
Ticlopidine—Pain—Etoposide—brain cancer	0.000184	0.00258	CcSEcCtD
Ticlopidine—Diarrhoea—Temozolomide—brain cancer	0.000184	0.00258	CcSEcCtD
Ticlopidine—Dizziness—Temozolomide—brain cancer	0.000177	0.0025	CcSEcCtD
Ticlopidine—Vomiting—Carmustine—brain cancer	0.000177	0.00248	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Etoposide—brain cancer	0.000176	0.00247	CcSEcCtD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000175	0.00331	CbGpPWpGaD
Ticlopidine—Rash—Carmustine—brain cancer	0.000175	0.00246	CcSEcCtD
Ticlopidine—Dermatitis—Carmustine—brain cancer	0.000175	0.00246	CcSEcCtD
Ticlopidine—Headache—Carmustine—brain cancer	0.000174	0.00245	CcSEcCtD
Ticlopidine—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000173	0.00327	CbGpPWpGaD
Ticlopidine—MPO—Selenium Micronutrient Network—RELA—brain cancer	0.000171	0.00324	CbGpPWpGaD
Ticlopidine—Vomiting—Temozolomide—brain cancer	0.000171	0.0024	CcSEcCtD
Ticlopidine—Urticaria—Etoposide—brain cancer	0.000171	0.0024	CcSEcCtD
Ticlopidine—Body temperature increased—Etoposide—brain cancer	0.00017	0.00239	CcSEcCtD
Ticlopidine—Rash—Temozolomide—brain cancer	0.000169	0.00238	CcSEcCtD
Ticlopidine—Dermatitis—Temozolomide—brain cancer	0.000169	0.00238	CcSEcCtD
Ticlopidine—Headache—Temozolomide—brain cancer	0.000168	0.00237	CcSEcCtD
Ticlopidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000168	0.00317	CbGpPWpGaD
Ticlopidine—Nausea—Carmustine—brain cancer	0.000165	0.00232	CcSEcCtD
Ticlopidine—P2RY12—brain—brain cancer	0.000162	0.0426	CbGeAlD
Ticlopidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00016	0.00302	CbGpPWpGaD
Ticlopidine—Nausea—Temozolomide—brain cancer	0.000159	0.00224	CcSEcCtD
Ticlopidine—Hypersensitivity—Etoposide—brain cancer	0.000158	0.00223	CcSEcCtD
Ticlopidine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000157	0.00298	CbGpPWpGaD
Ticlopidine—MPO—C-MYB transcription factor network—CCND1—brain cancer	0.000156	0.00296	CbGpPWpGaD
Ticlopidine—Asthenia—Etoposide—brain cancer	0.000154	0.00217	CcSEcCtD
Ticlopidine—Pruritus—Etoposide—brain cancer	0.000152	0.00214	CcSEcCtD
Ticlopidine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000151	0.00286	CbGpPWpGaD
Ticlopidine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000149	0.00282	CbGpPWpGaD
Ticlopidine—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000148	0.0028	CbGpPWpGaD
Ticlopidine—Diarrhoea—Etoposide—brain cancer	0.000147	0.00207	CcSEcCtD
Ticlopidine—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000146	0.00276	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000144	0.00272	CbGpPWpGaD
Ticlopidine—Dizziness—Etoposide—brain cancer	0.000142	0.002	CcSEcCtD
Ticlopidine—P2RY12—GPCR ligand binding—SHH—brain cancer	0.00014	0.00264	CbGpPWpGaD
Ticlopidine—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.00014	0.00264	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—PTCH2—brain cancer	0.000139	0.00263	CbGpPWpGaD
Ticlopidine—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000138	0.0026	CbGpPWpGaD
Ticlopidine—Vomiting—Etoposide—brain cancer	0.000137	0.00192	CcSEcCtD
Ticlopidine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000136	0.00256	CbGpPWpGaD
Ticlopidine—Rash—Etoposide—brain cancer	0.000135	0.00191	CcSEcCtD
Ticlopidine—Dermatitis—Etoposide—brain cancer	0.000135	0.0019	CcSEcCtD
Ticlopidine—Headache—Etoposide—brain cancer	0.000135	0.00189	CcSEcCtD
Ticlopidine—P2RY12—GPCR ligand binding—PTCH1—brain cancer	0.000133	0.00251	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR ligand binding—SMO—brain cancer	0.000133	0.00251	CbGpPWpGaD
Ticlopidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000129	0.00245	CbGpPWpGaD
Ticlopidine—MPO—pituitary gland—brain cancer	0.000129	0.0338	CbGeAlD
Ticlopidine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000128	0.00242	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—OR4C12—brain cancer	0.000128	0.00241	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—OR14C36—brain cancer	0.000128	0.00241	CbGpPWpGaD
Ticlopidine—Nausea—Etoposide—brain cancer	0.000128	0.0018	CcSEcCtD
Ticlopidine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000126	0.00239	CbGpPWpGaD
Ticlopidine—MPO—C-MYB transcription factor network—MYC—brain cancer	0.000125	0.00237	CbGpPWpGaD
Ticlopidine—MPO—Folate Metabolism—TP53—brain cancer	0.000125	0.00236	CbGpPWpGaD
Ticlopidine—CYP2D6—hindbrain—brain cancer	0.000121	0.0318	CbGeAlD
Ticlopidine—P2RY12—Hemostasis—TRPC6—brain cancer	0.000121	0.00228	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—ABR—brain cancer	0.00012	0.00228	CbGpPWpGaD
Ticlopidine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00012	0.00227	CbGpPWpGaD
Ticlopidine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000114	0.00216	CbGpPWpGaD
Ticlopidine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000113	0.00213	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000111	0.0021	CbGpPWpGaD
Ticlopidine—MPO—spinal cord—brain cancer	0.000111	0.029	CbGeAlD
Ticlopidine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.00011	0.00209	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—ABR—brain cancer	0.000109	0.00207	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—DTX2—brain cancer	0.000109	0.00205	CbGpPWpGaD
Ticlopidine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000105	0.00199	CbGpPWpGaD
Ticlopidine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000104	0.00196	CbGpPWpGaD
Ticlopidine—MPO—endocrine gland—brain cancer	9.96e-05	0.0261	CbGeAlD
Ticlopidine—MPO—head—brain cancer	9.83e-05	0.0258	CbGeAlD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	9.18e-05	0.00174	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—VAV1—brain cancer	9.03e-05	0.00171	CbGpPWpGaD
Ticlopidine—MPO—central nervous system—brain cancer	8.97e-05	0.0236	CbGeAlD
Ticlopidine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	8.9e-05	0.00168	CbGpPWpGaD
Ticlopidine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	8.78e-05	0.00166	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	8.31e-05	0.00157	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PTCH2—brain cancer	8.23e-05	0.00156	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HES5—brain cancer	7.97e-05	0.00151	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—IL2—brain cancer	7.83e-05	0.00148	CbGpPWpGaD
Ticlopidine—CYP2E1—telencephalon—brain cancer	7.77e-05	0.0204	CbGeAlD
Ticlopidine—P2RY12—Signaling Pathways—STRADA—brain cancer	7.74e-05	0.00146	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—TRPC6—brain cancer	7.62e-05	0.00144	CbGpPWpGaD
Ticlopidine—CYP2C8—pituitary gland—brain cancer	7.52e-05	0.0197	CbGeAlD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	7.48e-05	0.00142	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—SHH—brain cancer	7.17e-05	0.00136	CbGpPWpGaD
Ticlopidine—MPO—brain—brain cancer	7.12e-05	0.0187	CbGeAlD
Ticlopidine—CYP2D6—brainstem—brain cancer	6.94e-05	0.0182	CbGeAlD
Ticlopidine—P2RY12—Signaling by GPCR—TRPC6—brain cancer	6.92e-05	0.00131	CbGpPWpGaD
Ticlopidine—CYP2B6—gonad—brain cancer	6.91e-05	0.0182	CbGeAlD
Ticlopidine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.87e-05	0.0013	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—SMO—brain cancer	6.8e-05	0.00129	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—PTCH1—brain cancer	6.8e-05	0.00129	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.78e-05	0.00128	CbGpPWpGaD
Ticlopidine—CYP2C19—endocrine gland—brain cancer	6.67e-05	0.0175	CbGeAlD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—VEGFA—brain cancer	6.65e-05	0.00126	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ABR—brain cancer	6.46e-05	0.00122	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	6.36e-05	0.0012	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—GLI2—brain cancer	6.23e-05	0.00118	CbGpPWpGaD
Ticlopidine—CYP2D6—telencephalon—brain cancer	6.15e-05	0.0162	CbGeAlD
Ticlopidine—CYP2E1—medulla oblongata—brain cancer	6.11e-05	0.016	CbGeAlD
Ticlopidine—P2RY12—Signaling Pathways—GLI1—brain cancer	5.86e-05	0.00111	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	5.85e-05	0.00111	CbGpPWpGaD
Ticlopidine—CYP2C8—endocrine gland—brain cancer	5.82e-05	0.0153	CbGeAlD
Ticlopidine—P2RY12—Hemostasis—PIK3CG—brain cancer	5.73e-05	0.00108	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.72e-05	0.00108	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.72e-05	0.00108	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—VAV1—brain cancer	5.71e-05	0.00108	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—SUFU—brain cancer	5.56e-05	0.00105	CbGpPWpGaD
Ticlopidine—CYP1A2—endocrine gland—brain cancer	5.45e-05	0.0143	CbGeAlD
Ticlopidine—CYP2E1—spinal cord—brain cancer	5.45e-05	0.0143	CbGeAlD
Ticlopidine—CYP1A1—endocrine gland—brain cancer	5.38e-05	0.0141	CbGeAlD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.36e-05	0.00101	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—GFAP—brain cancer	5.36e-05	0.00101	CbGpPWpGaD
Ticlopidine—CYP1A1—head—brain cancer	5.31e-05	0.0139	CbGeAlD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.3e-05	0.001	CbGpPWpGaD
Ticlopidine—CYP2B6—endocrine gland—brain cancer	5.22e-05	0.0137	CbGeAlD
Ticlopidine—P2RY12—Signaling by GPCR—VAV1—brain cancer	5.18e-05	0.00098	CbGpPWpGaD
Ticlopidine—CYP2C9—endocrine gland—brain cancer	5.17e-05	0.0136	CbGeAlD
Ticlopidine—CYP2B6—head—brain cancer	5.16e-05	0.0135	CbGeAlD
Ticlopidine—P2RY12—Signaling Pathways—HEY1—brain cancer	5.08e-05	0.000961	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—DLL1—brain cancer	4.98e-05	0.000943	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.92e-05	0.00093	CbGpPWpGaD
Ticlopidine—CYP2E1—endocrine gland—brain cancer	4.9e-05	0.0129	CbGeAlD
Ticlopidine—CYP1A1—central nervous system—brain cancer	4.84e-05	0.0127	CbGeAlD
Ticlopidine—CYP2E1—head—brain cancer	4.84e-05	0.0127	CbGeAlD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.77e-05	0.000902	CbGpPWpGaD
Ticlopidine—CYP2B6—central nervous system—brain cancer	4.71e-05	0.0124	CbGeAlD
Ticlopidine—CYP2E1—central nervous system—brain cancer	4.42e-05	0.0116	CbGeAlD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.39e-05	0.00083	CbGpPWpGaD
Ticlopidine—CYP2E1—cerebellum—brain cancer	4.32e-05	0.0113	CbGeAlD
Ticlopidine—P2RY12—Signaling Pathways—SHH—brain cancer	4.24e-05	0.000802	CbGpPWpGaD
Ticlopidine—CYP2C8—brain—brain cancer	4.17e-05	0.0109	CbGeAlD
Ticlopidine—P2RY12—Signaling Pathways—TRPC6—brain cancer	4.09e-05	0.000773	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.05e-05	0.000767	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—IL2—brain cancer	4.04e-05	0.000763	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PTCH1—brain cancer	4.02e-05	0.00076	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—SMO—brain cancer	4.02e-05	0.00076	CbGpPWpGaD
Ticlopidine—CYP3A4—endocrine gland—brain cancer	3.95e-05	0.0104	CbGeAlD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.92e-05	0.000741	CbGpPWpGaD
Ticlopidine—CYP2D6—endocrine gland—brain cancer	3.88e-05	0.0102	CbGeAlD
Ticlopidine—CYP1A1—brain—brain cancer	3.85e-05	0.0101	CbGeAlD
Ticlopidine—CYP2D6—head—brain cancer	3.83e-05	0.0101	CbGeAlD
Ticlopidine—CYP2B6—brain—brain cancer	3.74e-05	0.00982	CbGeAlD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.73e-05	0.000706	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.65e-05	0.00069	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.65e-05	0.00069	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—PIK3CG—brain cancer	3.62e-05	0.000685	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.59e-05	0.00068	CbGpPWpGaD
Ticlopidine—CYP3A4—central nervous system—brain cancer	3.56e-05	0.00934	CbGeAlD
Ticlopidine—CYP2E1—brain—brain cancer	3.51e-05	0.00921	CbGeAlD
Ticlopidine—CYP2D6—central nervous system—brain cancer	3.5e-05	0.00919	CbGeAlD
Ticlopidine—P2RY12—Hemostasis—VEGFA—brain cancer	3.43e-05	0.000649	CbGpPWpGaD
Ticlopidine—CYP2D6—cerebellum—brain cancer	3.42e-05	0.00898	CbGeAlD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.42e-05	0.000647	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—PIK3CG—brain cancer	3.29e-05	0.000622	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NOTCH2—brain cancer	3.21e-05	0.000607	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.21e-05	0.000607	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—VAV1—brain cancer	3.06e-05	0.000579	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.93e-05	0.000553	CbGpPWpGaD
Ticlopidine—CYP2D6—brain—brain cancer	2.78e-05	0.00729	CbGeAlD
Ticlopidine—P2RY12—Signaling Pathways—HES1—brain cancer	2.63e-05	0.000498	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—TP53—brain cancer	2.59e-05	0.00049	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP2C9—brain cancer	2.59e-05	0.000489	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—IL2—brain cancer	2.55e-05	0.000482	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP2C9—brain cancer	2.53e-05	0.000479	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PDGFRA—brain cancer	2.51e-05	0.000474	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.5e-05	0.000473	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—SPP1—brain cancer	2.43e-05	0.00046	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP2C9—brain cancer	2.39e-05	0.000452	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—IL2—brain cancer	2.32e-05	0.000438	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IRS2—brain cancer	2.2e-05	0.000416	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—BSG—brain cancer	2.2e-05	0.000416	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.19e-05	0.000414	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—BSG—brain cancer	2.15e-05	0.000407	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—BSG—brain cancer	2.03e-05	0.000384	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.95e-05	0.00037	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CG—brain cancer	1.94e-05	0.000368	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—APC—brain cancer	1.94e-05	0.000368	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—IDH1—brain cancer	1.89e-05	0.000358	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—BSG—brain cancer	1.86e-05	0.000352	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—IDH1—brain cancer	1.85e-05	0.00035	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.8e-05	0.00034	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—EGFR—brain cancer	1.77e-05	0.000335	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—IDH1—brain cancer	1.75e-05	0.00033	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—BSG—brain cancer	1.66e-05	0.000314	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—IDH1—brain cancer	1.6e-05	0.000303	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—BSG—brain cancer	1.53e-05	0.000289	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.52e-05	0.000288	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—RELA—brain cancer	1.52e-05	0.000287	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—BSG—brain cancer	1.51e-05	0.000287	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ERBB2—brain cancer	1.51e-05	0.000285	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ENO2—brain cancer	1.49e-05	0.000283	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ENO2—brain cancer	1.46e-05	0.000277	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—IDH1—brain cancer	1.43e-05	0.00027	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.42e-05	0.000269	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ENO2—brain cancer	1.38e-05	0.000261	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL2—brain cancer	1.37e-05	0.000259	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCND1—brain cancer	1.33e-05	0.000252	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CTNNB1—brain cancer	1.32e-05	0.00025	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—IDH1—brain cancer	1.31e-05	0.000249	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.3e-05	0.000246	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—IDH1—brain cancer	1.3e-05	0.000246	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—BSG—brain cancer	1.29e-05	0.000245	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ENO2—brain cancer	1.27e-05	0.000239	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.18e-05	0.000222	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.16e-05	0.00022	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—VEGFA—brain cancer	1.16e-05	0.00022	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STAT3—brain cancer	1.15e-05	0.000218	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ENO2—brain cancer	1.13e-05	0.000214	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—IDH1—brain cancer	1.11e-05	0.000211	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MYC—brain cancer	1.07e-05	0.000202	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.06e-05	0.000201	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EGFR—brain cancer	1.05e-05	0.000198	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ENO2—brain cancer	1.04e-05	0.000196	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ENO2—brain cancer	1.03e-05	0.000195	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—BSG—brain cancer	9.99e-06	0.000189	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.06e-06	0.000171	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ENO2—brain cancer	8.8e-06	0.000166	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—brain cancer	8.79e-06	0.000166	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—IDH1—brain cancer	8.59e-06	0.000162	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CG—brain cancer	6.86e-06	0.00013	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ENO2—brain cancer	6.79e-06	0.000128	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CG—brain cancer	6.72e-06	0.000127	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CG—brain cancer	6.33e-06	0.00012	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CG—brain cancer	5.8e-06	0.00011	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.18e-06	9.8e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.77e-06	9.01e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.72e-06	8.93e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.04e-06	7.63e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.12e-06	5.89e-05	CbGpPWpGaD
